Experts from industry and interest groups together with a GMP inspector will provide an overview of regulations opportunities and risks associated with the use of AI in the pharmaceutical industry
What can AI do
Patient safety and AI how do they get along
Authorities view of AI
Meet Thescon at the Digital Life Sciences User Summit 2024 from May 14th to 15th in Münster
Dr Dmitrij Lisak Thescon Partner and Lead Consultant participates in the panel discussion on effective validation approaches and the impact of digital transformation on the regulated industry
WHO publishes guidelines for ethics and governance of large multimodal AI models
The WHO formulates guidelines to master the opportunities and challenges of LLMs
Real application examples and discussion with Thescon expert Ingo Baumann
What can AI do Patient safety and AI how do they get along Authorities 8217 view of AI
EMA and PIC s outline new compliance requirements for companies What 8217 s in store
Artificial intelligence the patient bears the risk
Artificial intelligence is the promise of better decisions faster processes and savings in personnel costs However patients pay the ultimate price for mistakes How does the life sciences industry deal with this risk
We want to do our bit 8211 and our customers support us
On the occasion of the global Climate day we want to do our bit to reduce CO2 emission We create the basis 8211 and our customers support us in making a difference
Technical innovations can convince at the Digital Life Sciences Day
Thescon was part of an exchange about opportunities and risks of the digital transformation for the regulated industry The event Digital Life Sciences Day was organized by Capgemini in Munich
Unternehmen teilt Wissen nach erfolgreichem Projektabschluss
Nach der Umstellung ihres ERP Systems teilt die Firma Inpac Medizintechnik GmbH Tipps und Tricks für eine erfolgreiche Projektverwirklichung Unterstützt wurde das Projekt von dem Validierungspartner Thescon